| ‘Therapeutic Alternatives’: Procurement Rules for Drugs with Same Indication but without Equivalence Certification Released According to the Balduzzi Law A Messori, V Fadda, S Trippoli Global & Regional Health Technology Assessment 2 (3), GRHTA. 5000202, 2015 | | 2015 |
| “Polypill” to fight cardiovascular disease: Cost effectiveness of statins for primary prevention of cardiovascular events is questionable A Messori, B Santarlasci, S Trippoli, M Vaiani BMJ 327 (7418), 808-809, 2003 | 10 | 2003 |
| “Real-world” endovascular versus surgical arteriovenous fistula economic evaluation: Can clinical outcomes and use of resources be derived from different countries? A Messori, L Bartoli, E Ferracane, S Trippoli The Journal of Vascular Access 24 (3), 515-515, 2023 | | 2023 |
| “Total evidence” network meta-analysis as a tool for improving the assessment of biosimilars: application to etanercept in rheumatoid arthritis A Messori, S Trippoli, C Marinai International Journal of Clinical Pharmacology and Therapeutics 55 (6), 517, 2017 | 4 | 2017 |
| “Value-based pricing” e “Payment by results”: strategia operativa, modelli computazionali e prospettive di applicazione nel campo dei dispositivi medici. S Adami, S Trippoli, S Simbula, A Messori | | |
| <> in the experience of the SIFO Laboratory of pharmacoeconomics CD Cervini, A Messori, S Trippoli, M Vaiani GIORNALE ITALIANO DI FARMACIA CLINICA 15 (4), 288-290, 2001 | | 2001 |
| <>, file-cards on new products with a simplified cost-effectivenes evaluation B Santarlasci, G Burchini, S Simbula, S Trippoli, A Messori GIORNALE ITALIANO DI FARMACIA CLINICA 22 (1), 24, 2008 | | 2008 |
| 19 Application of the clinical benefit of innovative drugs into an economic fig-ure A Messori, B Santarlasci, S Trippoli, M Vaiani 32nd European Symposium on Clinical Pharmacy Pharmacists in the Health-Care …, 2004 | | 2004 |
| A comparison of statistical analysis between" Real" patients reported in Kaplan-Meier curves and" Reconstructed" patients estimated through the IPDfromKM method: analysis of … A Messori, V Fadda, MR Romeo, S Veneziano, S Trippoli Cureus 15 (10), 2023 | 3 | 2023 |
| A disease management study in patients with hemorrhagic and ischemic stroke AM Grion, MC Giron, S Trippoli, A Messori | | 1998 |
| A disease management study in patients with resected colon cancer A Messori, S Trippoli, AM Grion, MC Giron | | 1998 |
| A new method for expressing survival and life expectancy in lifetime cost-effectiveness studies that evaluate cancer patients A Messori, S Trippoli Oncology reports 6 (5), 1135-1176, 1999 | 17 | 1999 |
| A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma A Messori, P Becagli, S Trippoli, E Tendi European Journal of Cancer 33 (9), 1373-1379, 1997 | 45 | 1997 |
| A uniform procedure for reimbursing the off-label use of antineoplastic drugs according to the value-for-money approach A Messori, V Fadda, S Trippoli Journal of Chemotherapy 23 (2), 67-70, 2011 | 6 | 2011 |
| Achieving sustained virological response in hepatitis C reduces the long-term risk of hepatocellular carcinoma: an updated meta-analysis employing relative and absolute outcome … A Messori, B Badiani, S Trippoli Clinical drug investigation 35, 843-850, 2015 | 25 | 2015 |
| Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy A Messori, V Fadda, D Maratea, S Trippoli Annals of hematology 92 (9), 1221-1228, 2013 | 15 | 2013 |
| Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost–utility analysis A Messori, S Trippoli, P Becagli, M Cincotta, MG Labbate, G Zaccara European journal of clinical pharmacology 53, 421-427, 1998 | 66 | 1998 |
| Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: a lifetime cost–utility analysis based on a modified Q-TWIST method S Trippoli, P Becagli, A Messori European journal of clinical pharmacology 53, 281-282, 1997 | 13 | 1997 |
| Adjuvant treatments in biliary tract cancer: an analysis based on restricted mean survival time A Messori, L Bartoli, S Trippoli Digestive and Liver Disease 52 (10), 1208-1209, 2020 | 3 | 2020 |
| Advanced HIV Infection Treated with Zidovudine Monotherapy: Lifetime Values of Absolute Cost—Effectiveness as a Pharmacoeconomic Reference for Future Studies Evaluating … A Messori, P Becagli, V Berto, S Trippoli, M Font, F Tosolini, F Venturini, ... Annals of Pharmacotherapy 31 (12), 1447-1454, 1997 | 12 | 1997 |
